955 results on '"Nappi, Rossella E."'
Search Results
2. Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause
3. Insights into the vulvar component of the genitourinary syndrome of menopause (GSM)
4. Menopause and endometriosis
5. Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: Findings from the REALISE study
6. Expression of miRNA from spent pre-implantation embryos culture media
7. Vulvovaginal atrophy in women with and without a history of breast cancer: Baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy
8. Perimenstrual Asthma and Premenstrual Disorders in Adolescents with Asthma
9. Sexual health and contraception in the menopause journey
10. Impact of climate and environmental change on the menopause
11. A forward-looking approach in women living with the Fontan circulation: from cardio-obstetric to cardio-reproductive medicine
12. Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortium
13. Biallelic mutations in PSMC3IP are associated with secondary amenorrhea: expanding the spectrum of premature ovarian insufficiency
14. Genitourinary syndrome of menopause: Should we treat symptoms or signs?
15. Menopause: a cardiometabolic transition
16. Medical Treatment of Female Sexual Dysfunction
17. Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study
18. Physician–patient alignment on menopause-associated symptom burden: real-world evidence from the USA and Europe.
19. Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper.
20. Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China.
21. Gene-environment interaction in functional hypothalamic amenorrhea.
22. Fezolinetant impact on health‐related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials.
23. Management of obesity in menopause.
24. POESIT recommendations on management of body-identical hormones in menopausal symptoms.
25. Real-world clinical evaluation of natural and induced vasomotor symptoms in the USA and Europe.
26. Expert opinion on the use of contraception in people with multiple sclerosis.
27. Quality of Life and Sexual Health
28. The role of hormone therapy in urogenital health after menopause
29. Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortium
30. Body Image and Other Mood Vulnerabilities in Adolescents with Polycystic Ovary Syndrome and Metabolic Alterations
31. Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)
32. Thyroid diseases and female sexual dysfunctions
33. Women’s cardiovascular health prevention: are we ready to change the road?
34. The significance of obesity for women’s sexuality in the life span
35. The metrics maze in science: navigating academic evaluation without journalistic pressures
36. Long-Term Consequences of Menopause
37. Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up
38. The Gynogram: A Multicentric Validation of a New Psychometric Tool to Assess Coital Pain Associated With VVA and Its Impact on Sexual Quality of Life in Menopausal Women
39. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
40. From couplepause to doublepause: the impact of midlife physical, psychological, and social changes on the sexual life of aging couples.
41. Hormonally Related Headaches
42. Oral Contraceptives for Menstrual Migraine with Aura
43. Perimenstrual asthma and premenstrual disorders in adolescents with asthma
44. When the ovaries speak to your heart.....are we ready to listen?
45. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM)
46. Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel
47. Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice
48. Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2).
49. Efficacy and safety of a device that combines multipolar radiofrequency with pulsed electromagnetic field for the treatment of vulvovaginal atrophy: a randomized, sham-controlled trial.
50. Overcoming barriers to oral contraception in Italy an expert opinion to empower women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.